title: Outer membrane protein vesicle vaccines for meningococcal disease.
abstract: Alternative strategies exist for prevention of group B Neisseria meningitidis (meningococcal) disease through vaccination (see Chapters 5 , 8 , 13 , 14 in this volume). However, the most promising approach to date has been the use of outer-membrane vesicle (OMV) vaccines for induction of bactericidal antibodies against cell-surface outer-membrane proteins (OMPs).
authors.affiliation: Division of Bacterial Products, Center for Biologics Evaluation and Research, Rockville, MD.
authors.forename: C E
authors.initials: CE
authors.lastname: Frasch
authors.forename: L
authors.initials: L
authors.lastname: van Alphen
authors.forename: J
authors.initials: J
authors.lastname: Holst
authors.forename: J T
authors.initials: JT
authors.lastname: Poolman
authors.forename: E
authors.initials: E
authors.lastname: Rosenqvist